4/A

FORM 4/A SUBMISSION

Company: PUMA BIOTECHNOLOGY, INC.
Filed: April 6, 2020
Period of Report: February 25, 2020
Accession Number: 0001209191-20-023599

View Document ↗ View on SEC.gov ↗